All-In with Chamath Jason Sacks And Friedberg
All-In with Chamath Jason Sacks And Friedberg

E65: VC markup dynamics, Russia/US tensions over Ukraine, Altos Labs raises $3B, Stripe mafia & more

0:00 Chamath's preferred cosplay 1:35 Reflecting on bad investment decisions and markup dynamics 15:20 Rising tensions between US and Russia over Ukraine, Putin's demands, NATO negotiations as the underreported key piece, Obama's savvy Russia dealings 39:16 Bill Ackman buys the Netfli

Featured Speakers

All-In Podcast, LLC Host

Topics Discussed

Episode Summary

Executive Summary: The episode swings from banter to a serious macro and geo discussion: the hosts debate market drawdowns, rate hikes, and venture valuations, arguing that current red markets create buying opportunities but also risk recession. They then pivot to Ukraine/Russia, where Sachs and Friedberg argue the U.S. should avoid war and NATO expansion, and later to biotech hype around Altos Labs, before closing on Bolt’s PR battle with Stripe and YC as an example of startup “punching up.”

Main Topics: Market drawdown, emotional investing, and price-taking (Priority: 5/5): The hosts discuss how to handle portfolio losses, distinguish trades from long-term investments, and avoid emotional decision-making during market selloffs. Sachs emphasizes being a price taker in both public and private markets. Fed tightening, recession risk, and liquidity withdrawal (Priority: 5/5): They analyze the Fed’s upcoming rate hikes, the impact of balance-sheet reduction, and the risk that policy overtightening could trigger recession despite strong labor and earnings data. Ukraine, Russia, NATO expansion, and war avoidance (Priority: 5/5): A long geopolitical segment argues that U.S. military involvement would be irresponsible, that NATO expansion helped provoke Russian insecurity, and that the most likely off-ramp is a pledge not to admit Ukraine into NATO. Supply-chain disruption and uneven economic signals (Priority: 4/5): The hosts debate whether strong wages, job openings, and savings outweigh ongoing supply chain bottlenecks that are hurting hardware, biotech, and consumer businesses. Biotech frontier: Altos Labs and age reversal science (Priority: 4/5): Friedberg explains new mouse data on Yamanaka factor reprogramming and frames Altos Labs’ $3B raise as a major bet on age reversal, while Chamath questions whether large, diffuse funding works better than focused startups. Bolt vs. Stripe/YC: startup PR, competition, and investing discipline (Priority: 3/5): The discussion centers on Bolt’s allegations against Stripe and YC. The hosts interpret it as a clever ‘punch up’ PR strategy and use it to revisit valuation discipline and missed investment opportunities.

Key Arguments: Market pain is best handled by separating true investments from short-term trades and by reducing emotional reactions to portfolio losses. Down markets improve entry prices for new investments, even while they hurt exits and recent marks. Venture firms are structurally pressured to mark up private companies because fundraising depends on paper gains and IRR optics. The Fed’s tightening cycle plus balance-sheet reduction could slow the economy and trigger recession if it overcorrects. Ukraine is not a vital U.S. national-security interest in the same way it is for Russia, so NATO expansion is an avoidable source of conflict. The U.S. and Europe can de-escalate by making clear Ukraine will not join NATO, or by using sanctions and energy pressure rather than military force. Supply-chain issues are real and not solved by rate hikes; they reflect pandemic-era shutoffs and global restarting friction. Altos Labs’ $3B raise is justified only if multiple research bets are needed to commercialize promising but uncertain science. Bolt’s attack on Stripe/YC worked as PR because it forced attention and elevated the company’s visibility, regardless of the merits. Great founders and businesses can still be undervalued by the market, so investors should be price takers rather than over-negotiators.

Data Points: Bitcoin entry price: $80 - Sachs says he first invested in Bitcoin in 2011 at this price. Bitcoin allocation guidance: 1% of net worth - Referenced as the share Sachs recommended in an old Bloomberg op-ed. Public portfolio return: Broke even / some up, some down - Sachs says his public holdings netted out roughly flat last year. Private book gain: $1 billion - Sachs says his private book was up a billion dollars on marks. Net fund return: ~15% - Sachs says the fund complex showed about 15% up, but he считает it was not real. Typical time to liquidity: 10-12 years - Used to argue that startup marks are inherently unstable and long-dated. U.S. troops on alert: 8,500 - Mentioned in the Ukraine discussion as being put on alert for possible deployment. German energy dependence on Russia: 50% - Hosts say roughly half of Germany’s natural gas/energy comes from Russia. Rate hikes expected: 5 hikes of 25 bps - Chamath says markets were pricing roughly five quarter-point hikes this year. Fed balance sheet: $9 trillion - Discussed as the scale of liquidity that could be withdrawn if the Fed sells assets. Unemployment rate: 3.5% - Used as evidence the economy is near full employment. Job openings: 10 million - Cited as a sign of strong labor demand. Tesla quarterly revenue: $17 billion - Discussed in the market/earnings segment as strong money-printing performance. Tesla revenue growth: 71% year over year - Chamath cites this growth alongside strong delivery growth. Tesla deliveries growth: 71% - Mentioned as part of Tesla’s strong quarter. Microsoft quarterly revenue: $51.7 billion - Used as another example of large-cap companies still printing cash. Microsoft net income: $18.8 billion - Cited as up more than 20% year over year. Altos Labs funding: $3 billion - Friedberg describes this as an unusually large seed-style bet on age reversal. Mouse biomarker age reversal: A few short bursts over about a week - Scientific paper described that Yamanaka factors reversed aging markers in mice. Bolt valuation: $14 billion - Sachs and Chamath reference Bolt’s current scale while discussing its PR strategy. Bolt round valuation discussed: $63 million - Sachs recalls an early Series A valuation from PitchBook. Potential missed return: 222x - Chamath jokes about the upside he might have captured if he had invested in Bolt. TCV Netflix investment: $200 million - Used as an example of a successful contrarian public/private crossover bet.

Pivotal Quotes: "If I confuse an investment with a trade, I'm done for." — Chamath Palihapitiya: On how he is trying to avoid emotional investing during a market drawdown. "Fortunes are made in the down market. They're collected in the up market." — Chamath Palihapitiya: Explaining why lower prices in public and private markets create opportunity. "The simplest thing to do to defuse this crisis would simply be to say, yes, we have no intention of adding Ukraine to NATO." — David Sacks: On the most direct diplomatic off-ramp in the Ukraine/Russia conflict discussion.

Implications: Listeners get a playbook for volatile markets: stay disciplined, treat valuations realistically, and expect opportunity in downturns. The episode also frames geopolitics as a major macro risk and suggests biotech’s next frontier may be large, science-first platform bets.

🔓 Sign Up for Unlimited Episode Search

About All-In with Chamath Jason Sacks And Friedberg

Industry veterans, degenerate gamblers & besties Chamath Palihapitiya, Jason Calacanis, David Sacks & David Friedberg cover all things economic, tech, political, social & poker.

View all episodes from All-In with Chamath Jason Sacks And Friedberg